1-20 of 69
Thomas C. Shea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients

George E. Hucks, Jr., Barbara Savoldo, Gianpietro Dotti, Catherine Joyce Arago Cheng, Caroline Babinec, Kimberly A. Kasow, Michael Winstead, Arpita Patel, Cammie Presler, Natalie S Grover, J. Kaitlin Morrison, Anne W. Beaven, Marcie L. Riches, Thomas C. Shea, Jonathan S. Serody
Journal: Blood
Blood (2021) 138 (Supplement 1): 2829.
https://doi.org/10.1182/blood-2021-153968
Published: 2021
Journal Articles

Equate, a Phase 1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of a Novel Targeted Anti-CD6 Therapy, Itolizumab, in Subjects with Newly Diagnosed Acute Graft Versus Host Disease

John Koreth, MBBS, DPhil, Saurabh Chhabra, MD, Joseph Pidala, MD, Thomas C. Shea, MD, Madan Jagasia, MBBS, MS, MMHC, Edmund K. Waller, PhDMD, Ryotaro Nakamura, MD, Marco Mielcarek, MD, George L. Chen, MD, Gabrielle Meyers, MD, Daanish Hoda, MD, Betty K. Hamilton, MD, Cherie Tracy Ng, PhD MPH, Mark Sonnemann, Susan Light, MD, Nuwan Nanayakkara, PhD, David Essayan, MD, Joel Rothman, BS, Stephen Connelly, PhD MBA, Krishna Polu, MD, Leslie Kean, MD PhD, Jerome Ritz, MD, Robert J. Soiffer, MD, Corey Cutler, MD MPH, FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 4516.
https://doi.org/10.1182/blood-2019-127325
Published: 2019
Journal Articles

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

Natalie S Grover, MD, Steven I Park, MD, Anastasia Ivanova, PhD, Paul Eldridge, PhD, Kathryn McKay, MS, MT (ASCP), Catherine Joyce Arago Cheng, BS, Spencer Laing, BA, Deborah Covington, RN, BSN, John West, PhD, S. Elizabeth Sharf, RN, BSN, J. Kaitlin Morrison, PhD, Shaw Scott, Erin Crecelius, MA, Desirae Shelley, Maurice Alexander, PharmD, Faith Brianne Buchanan, PA, Emily Herrick Kassam, NP, Megan McElfresh, PA-C, Alicia R Pinto, NP, Angela Denise Spruill, ANP, Ashley Zanter, ANP, Kimberly Wehner, FNP, Christopher Dittus, DO, Thomas C. Shea, MD, Gianpietro Dotti, MD, Jonathan S Serody, MD, Anne Beaven, MD, Barbara Savoldo, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 681.
https://doi.org/10.1182/blood-2018-99-113534
Published: 2018
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete Remission (CR1): An Alliance (A151509), SWOG, ECOG-ACRIN and CIBMTR Study

Celalettin Ustun, MD, Jennifer Le-Rademacher, PhD, Hai-Lin Wang, MPH, Megan Othus, Zhuoxin Sun, PhD, Brittny Major, Mei-Jie Zhang, PhD, Elizabeth Storrick, Jacqueline M Lafky, Selina Chow, Krzysztof Mrózek, MD PhD, Eyal C. Attar, MD, Clara D. Bloomfield, MD, Larry D Cripe, MD, Richard A. Larson, MD, Guido Marcucci, Gail J. Roboz, MD, Geoffrey L. Uy, MD, Richard M. Stone, MD, Aminah Jatoi, Thomas C. Shea, MD, Marcos de Lima, MD, James M. Foran, MD, Brenda M. Sandmaier, MD, Mark R. Litzow, MD, Harry P. Erba, MD PhD, Arti Hurria, MD, Daniel J. Weisdorf, MD, Andrew S Artz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2170.
https://doi.org/10.1182/blood-2018-99-118383
Published: 2018
Journal Articles

A Critical Role for Donor-Derived IL-22 in Cutaneous Chronic Gvhd

Kate H Gartlan, PhD, Hemamalini Bommiasamy, PhD, Katelyn Paz, Andrew Wilkinson, Mary Owen, Dawn Reichenbach, PhD, Tatjana Banovic, PhD MD, Kimberly Wehner, Faith Buchanan, Antiopi Varelias, PhD, Rachel Kuns, Karshing Chang, Yuri Fedoriw, MD, Thomas C. Shea, MD, James M. Coghill, Jr., MD, Michael Zaiken, Maximilian Plank, PhD, Paul Foster, Andrew Clouston, Bruce Blazar, MD, Jonathan S Serody, MD, Geoffrey R Hill, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 69.
https://doi.org/10.1182/blood.V130.Suppl_1.69.69
Published: 2017
Journal Articles

Impact of NCI Comprehensive Cancer Center Designation, Provider Specialization and Patient Sharing with Community Providers on Outcomes for Patients with Multiple Myeloma

Ashley T Freeman, MD, Lei Zhou, MSPH, Justin G Trogdon, PhD, Chris D Baggett, PhD, Sascha A Tuchman, MD, Thomas C. Shea, MD, William A. Wood, MD MPH
Journal: Blood
Blood (2017) 130 (Supplement 1): 529.
https://doi.org/10.1182/blood.V130.Suppl_1.529.529
Published: 2017
Journal Articles

Are outcomes of allografts for CLL still relevant?

Thomas C. Shea
Journal: Blood
Blood (2017) 130 (12): 1393–1394.
https://doi.org/10.1182/blood-2017-08-798561
Published: 2017
Journal Articles

Treatment of Venous Thromboembolism in Patients with Hematological Malignancies and Severe Thrombocytopenia: A Retrospective Cohort Analysis

Damon E. Houghton, MD, Jeffrey P. Laux, PhD, Nigel S. Key, MB, ChB, FRCP,, Neil A Zakai, MD MSc, Thomas C. Shea, MD, Stephan Moll, MD
Journal: Blood
Blood (2016) 128 (22): 531.
https://doi.org/10.1182/blood.V128.22.531.531
Published: 2016
Journal Articles

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Robert J. Soiffer, MD, Haesook T. Kim, PhD, Joseph McGuirk, DO, Mitchell E. Horwitz, MD, Laura Johnston, MD, Mrinal M Patnaik, MBBS, Witold Rybka, MD, Andrew Artz, MD, David L Porter, MD, Thomas C. Shea, MD, Michael W Boyer, MD, Richard T. Maziarz, MD, Madan H. Jagasia, MD, Paul J. Shaughnessy, MD, Usama Gergis, MD, Hana Safah, MD, Ran Reshef, MD, John F. DiPersio, MD PhD, Patrick J. Stiff, MD, Madhuri Vusirikala, MD, Jeff Szer, MB, BS, FRACP, Jennifer Holter, MD, James D. Levine, MD, Paul J. Martin, MD, Joseph A. Pidala, MD, Ian D. Lewis, MBBS PhDFRACP FRCPA, Vincent T. Ho, MD, Edwin P. Alyea, MD, Jerome Ritz, MD, Frank Glavin, Peter Westervelt, MD PhD, Yi-Bin Chen, MD
Journal: Blood
Blood (2016) 128 (22): 505.
https://doi.org/10.1182/blood.V128.22.505.505
Published: 2016
Journal Articles

Autologous Transplantation As Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG S9704 Intergroup Trial Subgroup Analysis

Patrick J. Stiff, MD, Hongli Li, PhD, James R. Cook, MD PhD, Louis S. Constine, MD, Stephen Couban, MD, Douglas A. Stewart, MD FRCPC, Thomas C. Shea, MD, Pierluigi Porcu, MD, Jane N. Winter, MD, Brad S Kahl, Sonali M. Smith, MD, Deborah Marcellus, MD, Kevin Barton, MD, Glenn M. Mills, MD, Michael LeBlanc, PhD, Lisa Rimsza, MD, Stephen J. Forman, MD, John P. Leonard, MD, Richard I. Fisher, MD, Jonathan Friedberg, MD
Journal: Blood
Blood (2016) 128 (22): 4651.
https://doi.org/10.1182/blood.V128.22.4651.4651
Published: 2016
Journal Articles

Rapid Assessment of Minimal Residual Acute Myeloid Leukemia from Peripheral Blood Using a Microfluidic Chip

Joshua M. Jackson, MS, James Taylor, BS, Malgorzata Witek, PhD, Sally A. Hunsucker, PhD, Jennifer Paulsen Waugh, MD, Yuri D. Fedoriw, MD, Thomas C. Shea, MD, Steven A. Soper, PhD, Paul M. Armistead, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1389.
https://doi.org/10.1182/blood.V126.23.1389.1389
Published: 2015
Journal Articles

Pre-Transplant R-Bendamustine Induces High Rates of Minimial Residual Disease in MCL Patients: Updated Results of S1106: US Intergroup Study of a Randomized Phase II Trial of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplants for Patients with Mantle Cell Lymphoma

Robert Chen, Hongli Li, PhD, Steven H. Bernstein, MD, Lisa M. Rimsza, MD, Stephen J. Forman, MD, Louis Constine, MD, Thomas C. Shea, MD, Amanda F. Cashen, MD, Kristie A. Blum, MD, Timothy S. Fenske, MD, Paul M. Barr, MD, Michael Leblanc, PhD, Richard I. Fisher, MD, Bruce D. Cheson, MD, Sonali M. Smith, MD, Malek Faham, Jennifer Wilkins, John P. Leonard, MD, Brad S. Kahl, MD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 518.
https://doi.org/10.1182/blood.V126.23.518.518
Published: 2015
Journal Articles

Statewide Geographic Variation and Impact of Center Expertise upon Outcomes for Adults with Acute Myeloid Leukemia (AML) in North Carolina

Ashley T Freeman, MD, Anne Marie Meyer, PhD, Andrew B Smitherman, MD, Lei Zhou, MSPH, Ethan M Basch, MD MSc, Thomas C. Shea, MD, William A. Wood, MD MPH
Journal: Blood
Blood (2015) 126 (23): 4479.
https://doi.org/10.1182/blood.V126.23.4479.4479
Published: 2015
Journal Articles

Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306

Reed Friend, MD, James Xenakis, Jonathan S Serody, MD, Terrance Comeau, MD, Don A. Gabriel, MD PhD, Stefanie Sarantopoulos, MD PhD, James Coghill, MD, William A. Wood, MD MPH, Andrew Sharf, Julia S Whitley, BS, Kamakshi Rao, PharmD, Christine M Walko, PharmD,BCOP, Anastasia Ivanova, PhD, Thomas C. Shea, MD, Paul M Armistead, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3117.
https://doi.org/10.1182/blood.V126.23.3117.3117
Published: 2015
Journal Articles

Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results

Beata Holkova, MD, Maciej Kmieciak, PhD, Prithviraj Bose, MD, Shuo Ma, MD PhD, Amy Kimball, MD PhD, Mary Beth Tombes, RN, Ellen Shrader, BS, Wen Wan, PhD, Caryn Weir-Wiggins, Elizabeth Stoddert, Amanda Garnett Singh, RN, BSN, April Dean, BS, Sarah Conine, PhD, Heidi Sankala, PhD, John D. Roberts, MD, Thomas C. Shea, MD, Steven Grant, MD
Journal: Blood
Blood (2014) 124 (21): 3050.
https://doi.org/10.1182/blood.V124.21.3050.3050
Published: 2014
Journal Articles

Interval Exercise Training (IET) Is Feasible and May Improve Cardiorespiratory Performance Prior to Hematopoietic Cell Transplantation

Mathew Meeneghan, MD, Anna Snavely, PhD, Abbie Smith-Ryan, PhD, Claudio L Battaglini, PhD, Bryce B Reeve, PhD, Ethan Basch, MD MSc, Antonia Bennett, PhD, Charlotte Shatten, MA, Brett Phillips, BS, Jonathan Serody, MD, PhD, Don A. Gabriel, MD PhD, Katarzyna Joanna Jamieson, MD, James Coghill, MD, Paul M. Armistead, MD PhD, Thomas C. Shea, MD, William A. Wood, MD MPH
Journal: Blood
Blood (2014) 124 (21): 2611.
https://doi.org/10.1182/blood.V124.21.2611.2611
Published: 2014
Journal Articles

CALGB 100801 (Alliance): A Phase II Multi-Center NCI Cooperative Group Study of the Addition of Azacitidine (AZA) to Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation for High Risk Myelodysplasia (MDS) and Older Patients with Acute Myeloid Leukemia (AML): Results of a “test dose” Strategy to Target Busulfan Exposure

Ravi Vij, MD, Vera Hars, MS, William Blum, MD, Tsiporah B. Shore, Aaron P. Rapoport, MD, Thomas C. Shea, MD, Eva Hoke, Richard M. Stone, MD, Paula Friedman, Kouros Owzar, PhD, Steven M. Devine, MD
Journal: Blood
Blood (2014) 124 (21): 543.
https://doi.org/10.1182/blood.V124.21.543.543
Published: 2014
Journal Articles

Antiretroviral Therapy Has Equalized Presentations and Short-Term Outcomes Between HIV+ and HIV- Lymphoma Patients in Lilongwe, Malawi

Satish Gopal, Yuri D. Fedoriw, MD, Nathan Montgomery, Agnes Moses, Richard Nyasosela, Yohannie Mlombe, Carlos Varela, Suzgo Mzumara, Maria Chikasema, Salama Itimu, Fred Chimzimu, Coxcilly Kampani, Robert Krysiak, Kristy L. Richards, PhD MD, Thomas C. Shea, MD, George Liomba
Journal: Blood
Blood (2014) 124 (21): 2626.
https://doi.org/10.1182/blood.V124.21.2626.2626
Published: 2014
Journal Articles

A Phase 2 Trial of Induction Chemotherapy with ABVD Followed By Brentuximab Vedotin Consolidation in Patients with Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma

Steven I. Park, MD, Kristy L. Richards, PhD MD, Oludamilola Olajide, MBBS, Nishitha M Reddy, M.B.B.S., Nilanjan Ghosh, MD PhD, Elizabeth E. Budde, MD PhD, Matthew C. Foster, MD, Allison M. Deal, MS, Jeanne F. Noe, PharmD, Thomas C. Shea, MD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4431.
https://doi.org/10.1182/blood.V124.21.4431.4431
Published: 2014
Journal Articles

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients

Clinical Trials & Observations
Edward A. Stadtmauer, Keith M. Sullivan, Francisco M. Marty, Sanjeet S. Dadwal, Genovefa A. Papanicolaou, Thomas C. Shea, Sherif B. Mossad, Charalambos Andreadis, Jo-Anne H. Young, Francis K. Buadi, Mohamed El Idrissi, Thomas C. Heineman, Elchonon M. Berkowitz
Journal: Blood
Blood (2014) 124 (19): 2921–2929.
https://doi.org/10.1182/blood-2014-04-573048
Published: 2014
Includes: Supplemental data